Gabriel Cabrera

Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease

Iván Bontempi, Miguel Hernán Vicco, Gabriel Cabrera et al. · Vaccine · 2015 · 47 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +11

Trans-sialidase-based vaccine candidate protects against <i>Trypanosoma cruzi</i> infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype

Estefanía Prochetto, Carolina Roldán, Iván Bontempi et al. · Oncotarget · 2017 · 34 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Development and assessment of a new cage-like particle adjuvant

Daiana Bertona, Nazarena Pujato, Iván Bontempi et al. · Journal of Pharmacy and Pharmacology · 2017 · 30 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Genetic Engineering of Lactococcus lactis Co-producing Antigen and the Mucosal Adjuvant 3′ 5′- cyclic di Adenosine Monophosphate (c-di-AMP) as a Design Strategy to Develop a Mucosal Vaccine Prototype

Ingrid M. Quintana, Martín Espariz, Silvina R. Villar et al. · Frontiers in Microbiology · 2018 · 29 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Protection of Mice against Shiga Toxin 2 (Stx2)-Associated Damage by Maternal Immunization with a Brucella Lumazine Synthase-Stx2 B Subunit Chimera

María Pilar Mejías, Gabriel Cabrera, Romina Jimena Fernández‐Brando et al. · Infection and Immunity · 2014 · 28 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16